GO
Loading...

Pfizer Inc

More

  • Early Glance: Pharmaceuticals companies Friday, 30 Jan 2015 | 11:13 AM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $71.55. Bristol-Myers Squibb Co. fell$. 54 or. 9 percent, to $60.60. Hospira fell $1.05 or 1.6 percent, to $63.73.

  • Jan 30- Eli Lilly and Co cut its 2015 revenue forecast, issued earlier this month, as the U.S. drugmaker expects a bigger hit from a stronger dollar. Large U.S. healthcare companies such as Johnson& Johnson, Pfizer Inc and Bristol-Myers Squibb Co have in the past weeks issued 2015 earnings forecasts below Wall Street expectations, citing the stronger dollar.

  • Final Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 6:14 PM ET

    Baxter International Inc. rose $1.22 or 1.7 percent, to $71.38. Bristol-Myers Squibb Co. fell$. 19 or. 3 percent, to $61.14. Hospira rose$. 13 or. 2 percent, to $64.78.

  • Abbott CEO losing no sleep over stronger dollar Thursday, 29 Jan 2015 | 3:15 PM ET

    Jan 29- Abbott Laboratories' chief executive officer is not worried about the stronger dollar, telling analysts on Thursday his company will better withstand its painful effects than rivals due to its European factories and growing sales of nutritional products, medical diagnostics and medical optics. Half of its sales are in emerging markets, like China and...

  • Most active New York Stock Exchange-traded stocks Thursday, 29 Jan 2015 | 1:23 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. AT&T Inc. was unchanged at $32.70 with 14,565,000 shares traded. Bank of America Corp. rose 1.0 percent to $15.35 with 45,663,700 shares traded.

  • Midday Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 1:23 PM ET

    Baxter International Inc. rose$. 68 or 1.0 percent, to $70.84. Bristol-Myers Squibb Co. fell$. 62 or 1.0 percent, to $60.72. Hospira fell$. 68 or 1.1 percent, to $63.97.

  • Jan 29- Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, forecast 2015 sales and earnings below analysts' expectations, becoming the latest U.S. healthcare company to warn about a strengthening dollar. The company expects profit to be hit by 58 cents in 2015. It forecast $7.22 to $7.40, excluding special items, below analysts'...

  • Early Glance: Pharmaceuticals companies Thursday, 29 Jan 2015 | 10:40 AM ET

    Baxter International Inc. rose$. 57 or. 8 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 77 or 1.3 percent, to $60.56. Hospira fell$. 49 or. 8 percent, to $64.16.

  • Harley-Davidson earnings fall but edge forecasts Thursday, 29 Jan 2015 | 10:35 AM ET
    Harley-Davidson riders reveal Project LiveWire, the first electric Harley-Davidson motorcycle, last June in New York.

    Harley-Davidson's earnings slipped as a stronger U.S. dollar hurt the motorcycle maker's bottom line, which still topped analyst expectations.

  • MILWAUKEE— Harley-Davidson's fourth-quarter earnings slipped as a stronger U.S. dollar hurt the motorcycle maker's bottom line, which still topped analyst expectations. Analysts expected, on average, earnings of 33 cents per share, according to Zacks Investment Research. Harley-Davidson Inc. shares climbed 71 cents to $63 in premarket trading Thursday 30...

  • Final Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 6:07 PM ET

    Baxter International Inc. fell$. 50 or. 7 percent, to $70.16. Bristol-Myers Squibb Co. fell$. 66 or 1.1 percent, to $61.33. Hospira fell$. 84 or 1.3 percent, to $64.65.

  • Midday Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 1:21 PM ET

    Baxter International Inc. rose$. 17 or. 2 percent, to $70.83. Bristol-Myers Squibb Co. rose$. 48 or. 8 percent, to $62.47. Hospira fell$. 21 or. 3 percent, to $65.28.

  • Most active New York Stock Exchange-traded stocks Wednesday, 28 Jan 2015 | 1:21 PM ET

    NEW YORK— A look at New York Stock Exchange 10 most-active stocks at the close of trading:. AK Steel Holding Corp. fell 7.8 percent to $3.92 with 26,056,200 shares traded. AT&T Inc. fell. 4 percent to $32.68 with 45,235,400 shares traded.

  • Early Glance: Pharmaceuticals companies Wednesday, 28 Jan 2015 | 10:41 AM ET

    Baxter International Inc. rose$. 27 or. 4 percent, to $70.93. Bristol-Myers Squibb Co. rose$. 66 or 1.1 percent, to $62.65. Hospira rose$. 30 or. 5 percent, to $65.79.

  • The real Deflategate you should be freaking about Wednesday, 28 Jan 2015 | 8:59 AM ET

    Deflation is an economic nightmare that is starting to look like a reality, and central bankers shouldn't be the only ones freaking out.

  • Why Pfizer will remain strong  Tuesday, 27 Jan 2015 | 6:45 PM ET

    Raghuram Selvaraju, Managing Director of Equity Research for Healthcare at MLV & Co, says there's lots of leverage the company can employ to sustain strong earnings growth.

  • Final Glance: Pharmaceuticals companies Tuesday, 27 Jan 2015 | 6:08 PM ET

    Baxter International Inc. fell$. 22 or. 3 percent, to $70.66. Bristol-Myers Squibb Co. fell$. 47 or. 8 percent, to $61.99. Hospira fell $1.01 or 1.5 percent, to $65.49.

  • *Apple, P&G, Stryker also see headwinds. NEW YORK, Jan 27- A slew of U.S. multinational companies, from DuPont to Procter& Gamble, showed that a strong U.S. dollar hurt their earnings, and several blue-chip exporters said the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors, including industrial companies such as 3 M Co,...

  • NEW YORK, Jan 27- Pfizer Inc said on Tuesday it agreed to pay $400 million to avert a trial in a class action lawsuit accusing the pharmaceutical giant of misleading investors in connection with off-label marketing. Pfizer disclosed the agreement-in-principle as it released its fourth-quarter results. "This resolution reflects a desire by the company to...

  • *Apple also at risk; Microsoft shares plummet on currency concern. NEW YORK, Jan 27- A slew of U.S. multinational companies from DuPont to Microsoft Corp showed that a strong U.S. dollar is hammering their earnings, with several blue chip exporters predicting the situation will get worse if the greenback holds its strength. The pain is hitting multiple sectors...